Current Group Members and their Research Areas
Decarboxylation catalysis
Reactivity of carbanionic Breslow intermediates.
Some Former Students and Postdoctorals
| Name | Current Position |
|---|---|
| Jik Chin | Professor, University of Toronto |
| Aizhou Wang | Scientific Associate, UHN, Thoracic Surgery |
| Wing-Cheong Tsui | CEO, HK Biotech (Cambridge, UK) |
| Graeme Howe | Professor, Queen's University |
| Greg Thatcher | Professor, University of Arizona |
| David Zechel | Professor, Queen's University |
| Michael Brandl | Senior Research Scientist, Gilead Pharmaceuticals |
| John Paul Pezacki | Professor, University of Ottawa |
| Stephen Bearne | Professor, Dalhousie University |
| Scott Taylor | Professor, University of Waterloo |
| Neil Branda | Professor, Simon Fraser University |
| Andrew Grant | Professor. Mount Allison University |
| Qingyan Hu | Senior Scientist, Regeneron Pharmaceuticals |
| Scott Mundle | Professor, University of Windsor and Great Lakes Inst. for Environmental Research |
| John Lam | Lead Program Manager, Microsoft, Seattle |
| Francine Lui | Scientist, Northern Biologicals, Toronto |
| Jolanta Wodzinska | Director, Innovative Products, Acanthus Research, Toronto |
| Ian Moore | Application Scientist, SCIEX |
| Steve Brookes | Senior Manager, Resilience Biotechnologies Inc |
| Amer Alagic | Research Director, Microbix Biosystems |
| Dongxin Hu | Senior Project Manger, A.U.G. Signals, Toronto |
| Michael Brandl | Principal Scientist, Myovant Sciences |
| Lisa Cameron | ‎Director, Commercial QC Laboratories, Teva Canada |
| Glenn Ikeda | CEO, Natco Pharma |
| Vittorio De Stefano | Principal at Bank of Canada |
| Vince Mazza | Managing Partner, Traverse Capital Partners |
| Philip Wasserstein | Neurologist, Palo Alto Medical Foundation |
| Steven Rathgeber | Pediatric Cardiologist, BC Children's Hospital |
| Khashayar Karimian | CEO, Arasto Pharmaceutical Chemicals, Tehran |
| Xianfeng Li | Research Leader, Anacor Pharmaceuticals, San Francisco |
| Yonghong Song | Staff Scientist, Myokardia Pharmaceuticals, San Francisco |
| Ian Gray | Director, Regulatory Affairs, Quality Assurance and Pharmacovigilance, Ipsen, England |
| Belinda Tsao Nivaggioli | CEO, Avencia Pharmaceuticals, California |
| Marcel Trachsel | CEO, INT/EXT Communications AG, Basel |
| Elizabeth Wilson | Staff Scientist, Treeline Biosciences, Massachusetts |
| Victoria Stergiopoulos | Physician-in-Chief, CAMH, Toronto |
| Andrew Pelling | Professor, Dept of Physics, Univ of Ottawa |
| Ruxandra Serbanescu | Professor, Dept of Physics, Univ of Toronto |
| Gerald Gish | Scientist, Cancer Biology, Lunenfeld Institute |